CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
14.86
+0.37 (2.55%)
Apr 17, 2025, 4:00 PM EDT - Market closed
CeriBell Revenue
In the year 2024, CeriBell had annual revenue of $65.44M with 44.71% growth. CeriBell had revenue of $18.53M in the quarter ending December 31, 2024, with 41.15% growth.
Revenue (ttm)
$65.44M
Revenue Growth
+44.71%
P/S Ratio
2.71
Revenue / Employee
$232,897
Employees
281
Market Cap
532.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 65.44M | 20.22M | 44.71% |
Dec 31, 2023 | 45.23M | 19.30M | 74.47% |
Dec 31, 2022 | 25.92M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCBLL News
- 5 days ago - FDA Clears Ceribell's Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - GlobeNewsWire
- 6 weeks ago - CeriBell, Inc. (CBLL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - CeriBell: A Leader In AI-Powered Seizure Detection - Seeking Alpha
- 2 months ago - Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference - GlobeNewsWire
- 2 months ago - Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - GlobeNewsWire
- 4 months ago - Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - CeriBell: Healthcare Technology Stock With A Promising Growth Outlook - Seeking Alpha